<\/p>\n
Mesacol OD<\/strong> \u03c0\u03b5\u03c1\u03b9\u03ad\u03c7\u03b5\u03b9 \u03bc\u03b5\u03c3\u03b1\u03bb\u03b1\u03bc\u03af\u03bd\u03b7<\/strong> (\u03b5\u03c0\u03af\u03c3\u03b7\u03c2 \u03b3\u03bd\u03c9\u03c3\u03c4\u03ae \u03c9\u03c2 \u03bc\u03b5\u03c3\u03b1\u03bb\u03b1\u03b6\u03af\u03bd\u03b7 \u03ae 5-\u03b1\u03bc\u03b9\u03bd\u03bf\u03c3\u03b1\u03bb\u03b9\u03ba\u03c5\u03bb\u03b9\u03ba\u03cc \u03bf\u03be\u03cd, 5-ASA) \u2014 \u03ad\u03bd\u03b1 \u03c4\u03bf\u03c0\u03b9\u03ba\u03cc \u03b5\u03bd\u03c4\u03b5\u03c1\u03b9\u03ba\u03cc \u03b1\u03bd\u03c4\u03b9\u03c6\u03bb\u03b5\u03b3\u03bc\u03bf\u03bd\u03ce\u03b4\u03b5\u03c2 \u03c6\u03ac\u03c1\u03bc\u03b1\u03ba\u03bf<\/strong> \u03c7\u03c1\u03b7\u03c3\u03b9\u03bc\u03bf\u03c0\u03bf\u03b9\u03b5\u03af\u03c4\u03b1\u03b9 \u03b3\u03b9\u03b1 \u03b3\u03b9\u03b1 \u03c4\u03b7 \u03b8\u03b5\u03c1\u03b1\u03c0\u03b5\u03af\u03b1 \u03c4\u03b7\u03c2 \u03b5\u03bb\u03ba\u03ce\u03b4\u03bf\u03c5\u03c2 \u03ba\u03bf\u03bb\u03af\u03c4\u03b9\u03b4\u03b1\u03c2 (UC) \u03ba\u03b1\u03b9 \u03c4\u03b7 \u03b4\u03b9\u03b1\u03c4\u03ae\u03c1\u03b7\u03c3\u03b7 \u03c4\u03b7\u03c2 \u03cd\u03c6\u03b5\u03c3\u03b7\u03c2<\/strong>. \u0394\u03c1\u03b1 \u03c4\u03bf\u03c0\u03b9\u03ba\u03ac<\/em> \u03c3\u03c4\u03bf \u03b5\u03bd\u03c4\u03b5\u03c1\u03b9\u03ba\u03cc \u03b5\u03c0\u03b9\u03b8\u03ae\u03bb\u03b9\u03bf, \u03ba\u03b1\u03c4\u03b1\u03c3\u03c4\u03ad\u03bb\u03bb\u03bf\u03bd\u03c4\u03b1\u03c2 \u03c4\u03b9\u03c2 \u03c6\u03bb\u03b5\u03b3\u03bc\u03bf\u03bd\u03ce\u03b4\u03b5\u03b9\u03c2 \u03bf\u03b4\u03bf\u03cd\u03c2 \u03c0\u03bf\u03c5 \u03c0\u03c1\u03bf\u03ba\u03b1\u03bb\u03bf\u03cd\u03bd \u03c4\u03b1 \u03b5\u03c0\u03b5\u03b9\u03c3\u03cc\u03b4\u03b9\u03b1 \u03c4\u03b7\u03c2 UC. \u03a3\u03b7\u03bc\u03b1\u03bd\u03c4\u03b9\u03ba\u03cc:<\/strong> \u03b7 \u03bc\u03b5\u03c3\u03b1\u03bb\u03b1\u03bc\u03af\u03bd\u03b7 \u03b5\u03af\u03bd\u03b1\u03b9 \u03cc\u03c7\u03b9 \u03b8\u03b5\u03c1\u03b1\u03c0\u03b5\u03af\u03b1 \u03b3\u03b9\u03b1 \u03c4\u03bf \u03c3\u03cd\u03bd\u03b4\u03c1\u03bf\u03bc\u03bf \u03b5\u03c5\u03b5\u03c1\u03ad\u03b8\u03b9\u03c3\u03c4\u03bf\u03c5 \u03b5\u03bd\u03c4\u03ad\u03c1\u03bf\u03c5 (IBS)<\/strong>. UC is a chronic inflammatory disease (IBD); IBS is a functional disorder with no bowel inflammation — different conditions, different drugs. For UC, mesalamine is first-line therapy in mild-to-moderate disease. Typical dose: 1.2 g once-daily; see dosing section. Once daily (OD\/MMX) or divided doses depending on formulation. Side effects are usually mild — headache, nausea, abdominal discomfort; rare renal effects warrant periodic kidney-function checks.<\/p>\n<\/div>\n \ud83d\udce6 \u039a\u03ac\u03b8\u03b5 \u03c0\u03b1\u03c1\u03b1\u03b3\u03b3\u03b5\u03bb\u03af\u03b1 \u03ba\u03b1\u03bb\u03cd\u03c0\u03c4\u03b5\u03c4\u03b1\u03b9 \u03b1\u03c0\u03cc \u03c4\u03b7\u03bd \u03a0\u03bf\u03bb\u03b9\u03c4\u03b9\u03ba\u03ae \u0395\u03b3\u03b3\u03cd\u03b7\u03c3\u03b7\u03c2 \u0395\u03c0\u03b1\u03bd\u03b1\u03c0\u03bf\u03c3\u03c4\u03bf\u03bb\u03ae\u03c2<\/strong><\/a> \u2014 \u03b5\u03ac\u03bd \u03c4\u03bf \u03b4\u03ad\u03bc\u03b1 \u03c3\u03b1\u03c2 \u03b4\u03b5\u03bd \u03c6\u03c4\u03ac\u03c3\u03b5\u03b9 \u03b5\u03bd\u03c4\u03cc\u03c2 20 \u03b5\u03c1\u03b3\u03ac\u03c3\u03b9\u03bc\u03c9\u03bd \u03b7\u03bc\u03b5\u03c1\u03ce\u03bd, \u03c4\u03bf \u03b5\u03c0\u03b1\u03bd\u03b1\u03c0\u03bf\u03c3\u03c4\u03ad\u03bb\u03bb\u03bf\u03c5\u03bc\u03b5.<\/p>\n \u03a4\u03b1 \u03b3\u03b5\u03bd\u03cc\u03c3\u03b7\u03bc\u03b1 \u03c6\u03ac\u03c1\u03bc\u03b1\u03ba\u03ac \u03bc\u03b1\u03c2 \u03c0\u03c1\u03bf\u03ad\u03c1\u03c7\u03bf\u03bd\u03c4\u03b1\u03b9 \u03b1\u03c0\u03cc \u03ba\u03b1\u03c4\u03b1\u03c3\u03ba\u03b5\u03c5\u03b1\u03c3\u03c4\u03ad\u03c2 \u03c0\u03bf\u03c5 \u03c0\u03b9\u03c3\u03c4\u03bf\u03c0\u03bf\u03b9\u03bf\u03cd\u03bd\u03c4\u03b1\u03b9 \u03b1\u03c0\u03cc \u03c4\u03b7\u03bd WHO-GMP \u03ba\u03b1\u03b9 \u03b1\u03c0\u03bf\u03c3\u03c4\u03ad\u03bb\u03bb\u03bf\u03bd\u03c4\u03b1\u03b9 \u03c0\u03b1\u03b3\u03ba\u03bf\u03c3\u03bc\u03af\u03c9\u03c2 \u03c3\u03b5 \u03b4\u03b9\u03b1\u03ba\u03c1\u03b9\u03c4\u03b9\u03ba\u03ae, \u03b1\u03c0\u03bb\u03ae \u03c3\u03c5\u03c3\u03ba\u03b5\u03c5\u03b1\u03c3\u03af\u03b1 \u2014 \u03c7\u03c9\u03c1\u03af\u03c2 \u03cc\u03bd\u03bf\u03bc\u03b1 \u03c6\u03b1\u03c1\u03bc\u03ac\u03ba\u03bf\u03c5 \u03c3\u03c4\u03bf \u03b5\u03be\u03c9\u03c4\u03b5\u03c1\u03b9\u03ba\u03cc \u03c4\u03bf\u03c5 \u03b4\u03ad\u03bc\u03b1\u03c4\u03bf\u03c2. \u039f\u03b9 \u03c0\u03bb\u03b7\u03c1\u03c9\u03bc\u03ad\u03c2 \u03bc\u03b5 \u03ba\u03ac\u03c1\u03c4\u03b1 \u03b4\u03c1\u03bf\u03bc\u03bf\u03bb\u03bf\u03b3\u03bf\u03cd\u03bd\u03c4\u03b1\u03b9 \u03bc\u03ad\u03c3\u03c9 \u03c1\u03c5\u03b8\u03bc\u03b9\u03c3\u03bc\u03ad\u03bd\u03bf\u03c5 \u03b5\u03c0\u03b5\u03be\u03b5\u03c1\u03b3\u03b1\u03c3\u03c4\u03ae (\u03bf\u03b9 \u03c0\u03b5\u03c1\u03b9\u03b3\u03c1\u03b1\u03c6\u03ad\u03c2 \u03b5\u03ba\u03ba\u03b1\u03b8\u03ac\u03c1\u03b9\u03c3\u03b7\u03c2 \u03c0\u03b5\u03c1\u03b9\u03bb\u03b1\u03bc\u03b2\u03ac\u03bd\u03bf\u03c5\u03bd \u03c1\u03c5\u03b8\u03bc\u03b9\u03c3\u03bc\u03ad\u03bd\u03bf \u03b5\u03c0\u03b5\u03be\u03b5\u03c1\u03b3\u03b1\u03c3\u03c4\u03ae \u03c0\u03bb\u03b7\u03c1\u03c9\u03bc\u03ce\u03bd \u03bc\u03b5 \u03ba\u03ac\u03c1\u03c4\u03b1 \u2014 \u03c0\u03bf\u03c4\u03ad \u201cMedsBase\u201d \u03ae \u03bf\u03c0\u03bf\u03b9\u03bf\u03b4\u03ae\u03c0\u03bf\u03c4\u03b5 \u03cc\u03bd\u03bf\u03bc\u03b1 \u03c6\u03b1\u03c1\u03bc\u03ac\u03ba\u03bf\u03c5). \u0393\u03af\u03bd\u03bf\u03bd\u03c4\u03b1\u03b9 \u03b4\u03b5\u03ba\u03c4\u03ad\u03c2 \u03ba\u03b1\u03b9 \u03c0\u03bb\u03b7\u03c1\u03c9\u03bc\u03ad\u03c2 \u03bc\u03b5 \u03ba\u03c1\u03c5\u03c0\u03c4\u03bf\u03bd\u03bf\u03bc\u03af\u03c3\u03bc\u03b1\u03c4\u03b1 \u03ba\u03b1\u03b9 \u03c4\u03c1\u03b1\u03c0\u03b5\u03b6\u03b9\u03ba\u03ae \u03bc\u03b5\u03c4\u03b1\u03c6\u03bf\u03c1\u03ac SEPA. \u039a\u03ac\u03b8\u03b5 \u03c0\u03b1\u03c1\u03b1\u03b3\u03b3\u03b5\u03bb\u03af\u03b1 \u03ba\u03b1\u03bb\u03cd\u03c0\u03c4\u03b5\u03c4\u03b1\u03b9 \u03b1\u03c0\u03cc \u03c4\u03b7\u03bd \u03a0\u03bf\u03bb\u03b9\u03c4\u03b9\u03ba\u03ae \u0395\u03c0\u03b1\u03bd\u03b1\u03c0\u03bf\u03c3\u03c4\u03bf\u03bb\u03ae\u03c2 \u0395\u03be\u03b1\u03c3\u03c6\u03b1\u03bb\u03af\u03c3\u03b5\u03ce\u03c2 \u03bc\u03b1\u03c2.<\/p>\n Mesacol OD is an oral \u03b1\u03bc\u03b9\u03bd\u03bf\u03c3\u03b1\u03bb\u03b9\u03ba\u03c5\u03bb\u03b9\u03ba\u03cc (5-ASA)<\/strong> \u03c6\u03ac\u03c1\u03bc\u03b1\u03ba\u03bf \u03c0\u03bf\u03c5 \u03c0\u03b5\u03c1\u03b9\u03ad\u03c7\u03b5\u03b9 \u03bc\u03b5\u03c3\u03b1\u03bb\u03b1\u03bc\u03af\u03bd\u03b7<\/strong> (1.2 g once-daily), supplied as MMX multi-matrix once-daily tablets. Manufactured by Sun Pharma in packs of 30, 60 or 90 tablets. Mesalamine is the active metabolite of older sulfasalazine — without the sulfapyridine moiety that caused most of sulfasalazine’s systemic side effects.<\/p>\n \u0397 \u03bc\u03b5\u03c3\u03b1\u03bb\u03b1\u03bc\u03af\u03bd\u03b7 \u03ad\u03c7\u03b5\u03b9 \u03b1\u03c0\u03bf\u03c4\u03b5\u03bb\u03ad\u03c3\u03b5\u03b9 \u03b8\u03b5\u03c1\u03b1\u03c0\u03b5\u03af\u03b1 \u03c0\u03c1\u03ce\u03c4\u03b7\u03c2 \u03b3\u03c1\u03b1\u03bc\u03bc\u03ae\u03c2 \u03b3\u03b9\u03b1 \u03ae\u03c0\u03b9\u03b1 \u03ad\u03c9\u03c2 \u03bc\u03ad\u03c4\u03c1\u03b9\u03b1 \u03b5\u03bb\u03ba\u03ce\u03b4\u03b7 \u03ba\u03bf\u03bb\u03af\u03c4\u03b9\u03b4\u03b1<\/strong> \u03b1\u03c0\u03cc \u03c4\u03b7 \u03b4\u03b5\u03ba\u03b1\u03b5\u03c4\u03af\u03b1 \u03c4\u03bf\u03c5 1980 \u03ba\u03b1\u03b9 \u03c3\u03c5\u03bd\u03b9\u03c3\u03c4\u03ac\u03c4\u03b1\u03b9 \u03c9\u03c2 \u03b8\u03b5\u03c1\u03b1\u03c0\u03b5\u03af\u03b1 \u03b5\u03c0\u03b1\u03b3\u03c9\u03b3\u03ae\u03c2 \u03ba\u03b1\u03b9 \u03c3\u03c5\u03bd\u03c4\u03ae\u03c1\u03b7\u03c3\u03b7\u03c2 \u03c3\u03cd\u03bc\u03c6\u03c9\u03bd\u03b1 \u03bc\u03b5 \u03c4\u03b9\u03c2 \u03bf\u03b4\u03b7\u03b3\u03af\u03b5\u03c2 \u03c4\u03b7\u03c2 ACG, ECCO \u03ba\u03b1\u03b9 BSG. \u0397 \u03b1\u03c1\u03c7\u03b9\u03ba\u03ae \u03b5\u03bc\u03c0\u03bf\u03c1\u03b9\u03ba\u03ae \u03bf\u03bd\u03bf\u03bc\u03b1\u03c3\u03af\u03b1 \u03bc\u03b5\u03c3\u03b1\u03bb\u03b1\u03bc\u03af\u03bd\u03b7\u03c2 Asacol \u03b5\u03b3\u03ba\u03c1\u03af\u03b8\u03b7\u03ba\u03b5 \u03c4\u03bf 1987\u00b7 \u03c3\u03ae\u03bc\u03b5\u03c1\u03b1 \u03c5\u03c0\u03ac\u03c1\u03c7\u03bf\u03c5\u03bd \u03c0\u03bf\u03bb\u03bb\u03ac \u03c3\u03c5\u03c3\u03c4\u03ae\u03bc\u03b1\u03c4\u03b1 \u03c0\u03b1\u03c1\u03ac\u03b4\u03bf\u03c3\u03b7\u03c2 (\u03b5\u03c0\u03b9\u03ba\u03b1\u03bb\u03c5\u03bc\u03bc\u03ad\u03bd\u03b1 \u03bc\u03b5 Eudragit, \u03bc\u03b9\u03ba\u03c1\u03bf\u03ba\u03cc\u03ba\u03ba\u03bf\u03c5\u03c2 \u03b1\u03b9\u03b8\u03c5\u03bb\u03bf\u03ba\u03c5\u03c4\u03c4\u03b1\u03c1\u03af\u03bd\u03b7\u03c2, \u03c0\u03bf\u03bb\u03c5-\u03bc\u03ae\u03c4\u03c1\u03b1 MMX) \u03c0\u03bf\u03c5 \u03ad\u03c7\u03bf\u03c5\u03bd \u03c3\u03c7\u03b5\u03b4\u03b9\u03b1\u03c3\u03c4\u03b5\u03af \u03b3\u03b9\u03b1 \u03bd\u03b1 \u03b1\u03c0\u03b5\u03bb\u03b5\u03c5\u03b8\u03b5\u03c1\u03ce\u03bd\u03bf\u03c5\u03bd \u03c4\u03b7 \u03bc\u03b5\u03c3\u03b1\u03bb\u03b1\u03bc\u03af\u03bd\u03b7 \u03c3\u03b5 \u03b4\u03b9\u03b1\u03c6\u03bf\u03c1\u03b5\u03c4\u03b9\u03ba\u03ac \u03c3\u03b7\u03bc\u03b5\u03af\u03b1 \u03c4\u03bf\u03c5 \u03b3\u03b1\u03c3\u03c4\u03c1\u03b5\u03bd\u03c4\u03b5\u03c1\u03b9\u03ba\u03bf\u03cd \u03c3\u03c5\u03c3\u03c4\u03ae\u03bc\u03b1\u03c4\u03bf\u03c2.<\/p>\n Mesacol OD is \u03b4\u03b5\u03bd<\/strong> \u03bc\u03b9\u03b1 \u03b8\u03b5\u03c1\u03b1\u03c0\u03b5\u03af\u03b1 \u03b3\u03b9\u03b1:<\/p>\n \u0397 \u03bc\u03b5\u03c3\u03b1\u03bb\u03b1\u03bc\u03af\u03bd\u03b7 \u03b5\u03af\u03bd\u03b1\u03b9 \u03bc\u03b9\u03b1 \u03c4\u03bf\u03c0\u03b9\u03ba\u03ae \u03b5\u03bd\u03c4\u03b5\u03c1\u03b9\u03ba\u03ae \u03b1\u03bd\u03c4\u03b9\u03c6\u03bb\u03b5\u03b3\u03bc\u03bf\u03bd\u03ce\u03b4\u03b7\u03c2 \u03bf\u03c5\u03c3\u03af\u03b1. \u039f \u03b1\u03ba\u03c1\u03b9\u03b2\u03ae\u03c2 \u03bc\u03b7\u03c7\u03b1\u03bd\u03b9\u03c3\u03bc\u03cc\u03c2 \u03c4\u03b7\u03c2 \u03b5\u03af\u03bd\u03b1\u03b9 \u03c0\u03bf\u03bb\u03c5\u03c0\u03b1\u03c1\u03b1\u03b3\u03bf\u03bd\u03c4\u03b9\u03ba\u03cc\u03c2, \u03c0\u03b5\u03c1\u03b9\u03bb\u03b1\u03bc\u03b2\u03ac\u03bd\u03bf\u03bd\u03c4\u03b1\u03c2 \u03c0\u03bf\u03bb\u03bb\u03ad\u03c2 \u03b1\u03bd\u03c4\u03b9\u03c6\u03bb\u03b5\u03b3\u03bc\u03bf\u03bd\u03ce\u03b4\u03b5\u03b9\u03c2 \u03bf\u03b4\u03bf\u03cd\u03c2 \u03c3\u03c4\u03b7 \u03b2\u03bb\u03b5\u03bd\u03bd\u03bf\u03b3\u03cc\u03bd\u03bf \u03c4\u03bf\u03c5 \u03c0\u03b1\u03c7\u03ad\u03bf\u03c2 \u03b5\u03bd\u03c4\u03ad\u03c1\u03bf\u03c5:<\/p>\n Because mesalamine’s target is the colonic mucosa, delivery is critical. The MMX multi-matrix once-daily tablets of Mesacol OD is designed to release active drug in the colon rather than being absorbed prematurely in the small intestine. Eudragit-S coating dissolves at pH ≥ 7 (terminal ileum\/colon); Eudragit-L at pH ≥ 6 (duodenum\/jejunum); ethylcellulose microgranules release continuously; MMX uses a lipophilic\/hydrophilic matrix for controlled colonic release.<\/p>\n Once-daily dosing:<\/strong> Mesacol OD is a high-strength MMX (multi-matrix) once-daily formulation. Typical dose: one 1.2 g or 2.4 g tablet taken in the morning with or after food; up to 4.8 g\/day for active moderate UC.<\/p>\n \u0397 \u03bc\u03b5\u03c3\u03b1\u03bb\u03b1\u03bc\u03af\u03bd\u03b7 \u03b5\u03af\u03bd\u03b1\u03b9 \u03c3\u03c5\u03bd\u03ae\u03b8\u03c9\u03c2 \u03ba\u03b1\u03bb\u03ac \u03b1\u03bd\u03b5\u03ba\u03c4\u03ae \u03c3\u03b5 \u03c3\u03cd\u03b3\u03ba\u03c1\u03b9\u03c3\u03b7 \u03bc\u03b5 \u03c4\u03b7 \u03c3\u03bf\u03c5\u03bb\u03c6\u03b1\u03c3\u03b1\u03bb\u03b1\u03b6\u03af\u03bd\u03b7 \u03ba\u03b1\u03b9 \u03c4\u03bf\u03c5\u03c2 \u03b1\u03bd\u03bf\u03c3\u03bf\u03b4\u03b9\u03b1\u03bc\u03bf\u03c1\u03c6\u03c9\u03c4\u03ad\u03c2.<\/p>\n \u03a3\u03c5\u03c7\u03bd\u03ad\u03c2:<\/strong><\/p>\n \u03a3\u03c0\u03ac\u03bd\u03b9\u03b1 \u03b1\u03bb\u03bb\u03ac \u03c3\u03b7\u03bc\u03b1\u03bd\u03c4\u03b9\u03ba\u03ac:<\/strong><\/p>\n Store Mesacol OD below 25°C in a dry place, in the original blister. Keep out of reach of children. Protect from light and moisture.<\/p>\n Yes — all three names refer to the same molecule (5-aminosalicylic acid). Mesalamine is the US adopted name (USAN); mesalazine is the international non-proprietary name (INN); 5-ASA is the chemical abbreviation. Different brands and regions label it differently.<\/p>\n No — mesalamine does not treat IBS. IBS is a functional disorder; there is no mucosal inflammation for mesalamine to work on. For IBS, first-line treatments are dietary changes (low-FODMAP diet, fibre modification), antispasmodics like mebeverine (Colospa) or hyoscine, and — for IBS-D specifically — short courses of rifaximin (Rifagut). Central modulators (low-dose amitriptyline) are used for refractory IBS pain.<\/p>\n Symptom improvement typically begins within 1–2 weeks; full remission in 4–8 weeks at induction doses. Stool frequency and urgency usually improve first, followed by abdominal pain and finally mucosal healing (visible on colonoscopy at 8–12 weeks).<\/p>\n \u039f\u03b9 \u03c0\u03b5\u03c1\u03b9\u03c3\u03c3\u03cc\u03c4\u03b5\u03c1\u03bf\u03b9 \u03b1\u03c3\u03b8\u03b5\u03bd\u03b5\u03af\u03c2 \u03bc\u03b5 \u03b5\u03bb\u03ba\u03ce\u03b4\u03b7 \u03ba\u03bf\u03bb\u03af\u03c4\u03b9\u03b4\u03b1 \u03c7\u03c1\u03b5\u03b9\u03ac\u03b6\u03bf\u03bd\u03c4\u03b1\u03b9 \u03bc\u03b1\u03ba\u03c1\u03bf\u03c0\u03c1\u03cc\u03b8\u03b5\u03c3\u03bc\u03b7 \u03c3\u03c5\u03bd\u03c4\u03ae\u03c1\u03b7\u03c3\u03b7 \u03bc\u03b5 \u03bc\u03b5\u03c3\u03b1\u03bb\u03b1\u03bc\u03af\u03bd\u03b7 \u03b3\u03b9\u03b1 \u03bd\u03b1 \u03c0\u03b1\u03c1\u03b1\u03bc\u03b5\u03af\u03bd\u03bf\u03c5\u03bd \u03c3\u03b5 \u03cd\u03c6\u03b5\u03c3\u03b7 \u2014 \u03c3\u03c5\u03bd\u03ae\u03b8\u03c9\u03c2 \u03c4\u03bf\u03c5\u03bb\u03ac\u03c7\u03b9\u03c3\u03c4\u03bf\u03bd 1,6\u20132,4 g\/\u03b7\u03bc\u03ad\u03c1\u03b1. \u0397 \u03b4\u03b9\u03b1\u03ba\u03bf\u03c0\u03ae \u03bc\u03b5\u03c4\u03ac \u03c4\u03b7\u03bd \u03b5\u03c0\u03af\u03c4\u03b5\u03c5\u03be\u03b7 \u03cd\u03c6\u03b5\u03c3\u03b7\u03c2 \u03bf\u03b4\u03b7\u03b3\u03b5\u03af \u03c3\u03b5 \u03c5\u03c0\u03bf\u03c4\u03c1\u03bf\u03c0\u03ae \u03b5\u03bd\u03c4\u03cc\u03c2 6\u201312 \u03bc\u03b7\u03bd\u03ce\u03bd \u03c3\u03c4\u03b9\u03c2 \u03c0\u03b5\u03c1\u03b9\u03c3\u03c3\u03cc\u03c4\u03b5\u03c1\u03b5\u03c2 \u03bc\u03b5\u03bb\u03ad\u03c4\u03b5\u03c2. \u0397 \u03bc\u03b5\u03c3\u03b1\u03bb\u03b1\u03bc\u03af\u03bd\u03b7 \u03b5\u03af\u03bd\u03b1\u03b9 \u03b1\u03c3\u03c6\u03b1\u03bb\u03ae\u03c2 \u03b3\u03b9\u03b1 \u03b4\u03b5\u03ba\u03b1\u03b5\u03c4\u03af\u03b5\u03c2 \u03c7\u03c1\u03ae\u03c3\u03b7\u03c2 \u03cc\u03c4\u03b1\u03bd \u03c0\u03b1\u03c1\u03b1\u03ba\u03bf\u03bb\u03bf\u03c5\u03b8\u03b5\u03af\u03c4\u03b1\u03b9 \u03b7 \u03bd\u03b5\u03c6\u03c1\u03b9\u03ba\u03ae \u03bb\u03b5\u03b9\u03c4\u03bf\u03c5\u03c1\u03b3\u03af\u03b1.<\/p>\n \u0391\u03c1\u03ba\u03b5\u03c4\u03ad\u03c2 \u03bc\u03bf\u03c1\u03c6\u03ad\u03c2 \u03bc\u03b5\u03c3\u03b1\u03bb\u03b1\u03bc\u03af\u03bd\u03b7\u03c2 (\u03b5\u03b9\u03b4\u03b9\u03ba\u03ac \u03c4\u03b1 MMX \u201c\u03c6\u03ac\u03bd\u03c4\u03b1\u03c3\u03bc\u03b1\u201d \u03b4\u03b9\u03c3\u03ba\u03af\u03b1) \u03c0\u03b5\u03c1\u03bd\u03bf\u03cd\u03bd \u03c3\u03c4\u03b1 \u03ba\u03cc\u03c0\u03c1\u03b1\u03bd\u03b1 \u03c3\u03b5 \u03bc\u03b5\u03b3\u03ac\u03bb\u03bf \u03b2\u03b1\u03b8\u03bc\u03cc \u03ac\u03b8\u03b9\u03ba\u03c4\u03b5\u03c2. \u0391\u03c5\u03c4\u03cc \u03b5\u03af\u03bd\u03b1\u03b9 \u03b1\u03bd\u03b1\u03bc\u03b5\u03bd\u03cc\u03bc\u03b5\u03bd\u03b7<\/em> \u03ba\u03b1\u03b9 \u03c4\u03bf \u03c6\u03ac\u03c1\u03bc\u03b1\u03ba\u03bf \u03ad\u03c7\u03b5\u03b9 \u03b1\u03c0\u03b5\u03bb\u03b5\u03c5\u03b8\u03b5\u03c1\u03c9\u03b8\u03b5\u03af \u03bc\u03ad\u03c3\u03b1 \u03c3\u03c4\u03bf \u03ba\u03cc\u03bb\u03bf\u03bd \u03cc\u03c0\u03c9\u03c2 \u03c3\u03c7\u03b5\u03b4\u03b9\u03ac\u03c3\u03c4\u03b7\u03ba\u03b5. \u0391\u03bd \u03b2\u03bb\u03ad\u03c0\u03b5\u03c4\u03b5 \u03c4\u03bf \u03b4\u03b9\u03c3\u03ba\u03af\u03bf \u03b1\u03bc\u03b5\u03c4\u03ac\u03b2\u03bb\u03b7\u03c4\u03bf \u03c7\u03c9\u03c1\u03af\u03c2 \u03b2\u03bb\u03ac\u03b2\u03b7 \u03c3\u03c4\u03bf \u03b5\u03c0\u03b9\u03ba\u03ac\u03bb\u03c5\u03bc\u03bc\u03b1, \u03b5\u03bb\u03ad\u03b3\u03be\u03c4\u03b5 \u03c4\u03b7\u03bd \u03c4\u03b5\u03c7\u03bd\u03b9\u03ba\u03ae \u03c3\u03b1\u03c2\u00b7 \u03b4\u03b9\u03b1\u03c6\u03bf\u03c1\u03b5\u03c4\u03b9\u03ba\u03ac \u03b4\u03b5\u03bd \u03b1\u03c0\u03b1\u03b9\u03c4\u03b5\u03af\u03c4\u03b1\u03b9 \u03ba\u03b1\u03bc\u03af\u03b1 \u03b5\u03bd\u03ad\u03c1\u03b3\u03b5\u03b9\u03b1.<\/p>\n \u0393\u03b9\u03b1 \u03c4\u03bf\u03bd \u03c0\u03cc\u03bd\u03bf \u03c3\u03c4\u03b7\u03bd \u03b5\u03bb\u03ba\u03ce\u03b4\u03b7 \u03ba\u03bf\u03bb\u03af\u03c4\u03b9\u03b4\u03b1 \u03c0\u03c1\u03bf\u03c4\u03b9\u03bc\u03ac\u03c4\u03b1\u03b9 \u03bf \u03b2\u03c1\u03b1\u03c7\u03cd\u03b2\u03b9\u03bf\u03c2 \u03c0\u03b1\u03c1\u03b1\u03ba\u03b5\u03c4\u03b1\u03bc\u03cc\u03bb\u03b7 (\u03b1\u03ba\u03b5\u03c4\u03b1\u03bc\u03b9\u03bd\u03bf\u03c6\u03b1\u03af\u03bd\u03b7). \u0397 \u03c7\u03c1\u03cc\u03bd\u03b9\u03b1 \u03c7\u03c1\u03ae\u03c3\u03b7 NSAIDs \u03bc\u03c0\u03bf\u03c1\u03b5\u03af \u03c4\u03cc\u03c3\u03bf \u03bd\u03b1 \u03c0\u03c1\u03bf\u03ba\u03b1\u03bb\u03ad\u03c3\u03b5\u03b9 \u03b5\u03c0\u03b9\u03b4\u03b5\u03af\u03bd\u03c9\u03c3\u03b7 \u03c4\u03b7\u03c2 \u03b5\u03bb\u03ba\u03ce\u03b4\u03bf\u03c5\u03c2 \u03ba\u03bf\u03bb\u03af\u03c4\u03b9\u03b4\u03b1\u03c2 \u03ba\u03b1\u03b9<\/em> \u03cc\u03c3\u03bf \u03ba\u03b1\u03b9 \u03bd\u03b1 \u03b1\u03c5\u03be\u03ae\u03c3\u03b5\u03b9 \u03c4\u03b7 \u03bd\u03b5\u03c6\u03c1\u03b9\u03ba\u03ae \u03b5\u03c0\u03b9\u03ba\u03b9\u03bd\u03b4\u03c5\u03bd\u03cc\u03c4\u03b7\u03c4\u03b1 \u03c4\u03b7\u03c2 \u03bc\u03b5\u03c3\u03b1\u03bb\u03b1\u03bc\u03af\u03bd\u03b7\u03c2 \u2014 \u03b1\u03c0\u03bf\u03c6\u03b5\u03cd\u03b3\u03b5\u03c4\u03b5 \u03cc\u03c0\u03bf\u03c5 \u03b5\u03af\u03bd\u03b1\u03b9 \u03b4\u03c5\u03bd\u03b1\u03c4\u03cc\u03bd. \u0397 \u03c0\u03b5\u03c1\u03b9\u03c3\u03c4\u03b1\u03c3\u03b9\u03b1\u03ba\u03ae \u03c7\u03c1\u03ae\u03c3\u03b7 \u03c3\u03c5\u03bd\u03ae\u03b8\u03c9\u03c2 \u03b1\u03bd\u03ad\u03c7\u03b5\u03c4\u03b1\u03b9.<\/p>\n You can order Mesacol OD (1.2 g once-daily) from MedsBase in packs of 30, 60 or 90 tablets. We ship worldwide with discreet packaging and genuine WHO-GMP certified manufacturer stock.<\/p>\n <\/p>\n \u0386\u03bb\u03bb\u03b1 \u03c0\u03c1\u03bf\u03ca\u03cc\u03bd\u03c4\u03b1 \u03c3\u03b5 \u03a7\u03c1\u03cc\u03bd\u03b9\u03b5\u03c2 \u03a0\u03b1\u03b8\u03ae\u03c3\u03b5\u03b9\u03c2<\/strong> \u03c0\u03bf\u03c5 \u03bf\u03b9 \u03c0\u03b5\u03bb\u03ac\u03c4\u03b5\u03c2 \u03b5\u03be\u03b5\u03c4\u03ac\u03b6\u03bf\u03c5\u03bd \u03b5\u03c0\u03af\u03c3\u03b7\u03c2:<\/p>\n \u2705 Reduces bowel inflammation Mesacol OD contains Mesalamine.<\/p>","protected":false},"featured_media":58766,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3565],"product_tag":[4564,3566],"class_list":{"0":"post-58765","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-irritable-bowel-syndrome-ibs-treatment","9":"product_tag-mesacol-od","10":"product_tag-mesalamine","12":"first","13":"instock","14":"shipping-taxable","15":"purchasable","16":"product-type-variable","17":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product\/58765","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/comments?post=58765"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/media\/58766"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/media?parent=58765"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product_brand?post=58765"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product_cat?post=58765"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product_tag?post=58765"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}\u0393\u03b9\u03b1\u03c4\u03af \u03bd\u03b1 \u03c0\u03b1\u03c1\u03b1\u03b3\u03b3\u03b5\u03af\u03bb\u03b5\u03c4\u03b5 \u03b1\u03c0\u03cc \u03c4\u03b7 MedsBase<\/h3>\n
What Is Mesacol OD?<\/h2>\n
What Is Mesacol OD Used For?<\/h2>\n
\n
\n
How Does Mesacol OD Work?<\/h2>\n
\n
\u0394\u03bf\u03c3\u03bf\u03bb\u03bf\u03b3\u03af\u03b1 \u03ba\u03b1\u03b9 \u03a7\u03bf\u03c1\u03ae\u03b3\u03b7\u03c3\u03b7<\/h2>\n
\n
\u03a0\u03b1\u03c1\u03b5\u03bd\u03ad\u03c1\u03b3\u03b5\u03b9\u03b5\u03c2<\/h2>\n
\n
\n
\u0391\u03bb\u03bb\u03b7\u03bb\u03b5\u03c0\u03b9\u03b4\u03c1\u03ac\u03c3\u03b5\u03b9\u03c2 \u03a6\u03b1\u03c1\u03bc\u03ac\u03ba\u03c9\u03bd<\/h2>\n
\n
Who Should Not Take Mesacol OD?<\/h2>\n
\n
\u0391\u03c0\u03bf\u03b8\u03ae\u03ba\u03b5\u03c5\u03c3\u03b7<\/h2>\n
\u03a3\u03c5\u03c7\u03bd\u03ad\u03c2 \u0395\u03c1\u03c9\u03c4\u03ae\u03c3\u03b5\u03b9\u03c2<\/h2>\n
Is mesalamine the same as mesalazine or 5-ASA?<\/h3>\n
Can I take Mesacol OD for IBS or general bloating?<\/h3>\n
How long until Mesacol OD works?<\/h3>\n
Do I need to take Mesacol OD forever?<\/h3>\n
\u0393\u03b9\u03b1\u03c4\u03af \u03b2\u03bb\u03ad\u03c0\u03c9 \u03ac\u03b8\u03b9\u03ba\u03c4\u03bf\u03c5\u03c2 \u03ba\u03b5\u03bb\u03cd\u03c6\u03bf\u03c5\u03c2 \u03b4\u03b9\u03c3\u03ba\u03af\u03c9\u03bd \u03c3\u03c4\u03b1 \u03ba\u03cc\u03c0\u03c1\u03b1\u03bd\u03ac \u03bc\u03bf\u03c5;<\/h3>\n
Can I take aspirin or NSAIDs with Mesacol OD?<\/h3>\n
Where can I buy Mesacol OD online?<\/h3>\n
\u03a3\u03c7\u03b5\u03c4\u03b9\u03ba\u03ac \u03c6\u03ac\u03c1\u03bc\u03b1\u03ba\u03b1 \u03b3\u03b9\u03b1 \u03c4\u03bf \u03c3\u03cd\u03bd\u03b4\u03c1\u03bf\u03bc\u03bf \u03b5\u03c5\u03b5\u03c1\u03ad\u03b8\u03b9\u03c3\u03c4\u03bf\u03c5 \u03b5\u03bd\u03c4\u03ad\u03c1\u03bf\u03c5 (IBS) \u03ba\u03b1\u03b9 \u03c6\u03bb\u03b5\u03b3\u03bc\u03bf\u03bd\u03ce\u03b4\u03b7 \u03bd\u03cc\u03c3\u03bf \u03c4\u03bf\u03c5 \u03b5\u03bd\u03c4\u03ad\u03c1\u03bf\u03c5 (IBD)<\/h2>\n
\n
\u03a3\u03c7\u03b5\u03c4\u03b9\u03ba\u03ad\u03c2 \u0395\u03bd\u03b1\u03bb\u03bb\u03b1\u03ba\u03c4\u03b9\u03ba\u03ad\u03c2<\/h3>\n
\n
\n\u2705 Relieves abdominal pain
\n\u2705 Improves stool consistency
\n\u2705 Prevents flare-ups
\n\u2705 Treats ulcerative colitis<\/p>\n